Search Results
News Release
Investigators with The Cancer Genome Atlas Research Network have identified new potential therapeutic targets for a major form of bladder cancer.
… a repertoire of possibilities for developing new cancer therapeutics." The scientists also uncovered a potential …
Staff
Sangeetha Raghavan is a Senior Licensing and Patenting Manager in NHGRI's Technology Transfer Office.
… ranging areas of biologics, diagnostics, drug delivery, therapeutics, medical devices, plant varieties, small … Licensing, biologics, diagnostics, drug delivery, therapeutics, medical devices, plant varieties, small …
News Release
A team from the NIH has surmounted a major obstacle to testing potential drug therapies for a rare, genetic condition called Gaucher disease.
News Release
Researchers from The Cancer Genome Atlas Research Network identify novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma.
News Release
NIH researchers compared a new genetic animal model of Down syndrome to the standard model and found the updated version to be enhanced.
Health
Genomic medicine involves using genomic information as part of clinical care and the health outcomes and policy implications of that clinical use.
Research at NHGRI
The NHGRI Office of the Clinical Director supports world-class clinical research and enhances the education of genetics investigators at all levels.
Partner with NHGRI
NHGRI's technologies, inventions and discoveries are available for licensing.
… for licensing, including candidate gene therapy-based therapeutics, mouse models of genetic disorders and a diverse …
Event
The Excellence in Clinical Research Seminar Series is designed to facilitate clinical research in the rare disease space with a focus on aspects of regulatory medicine and clinical trials in Mendelian disorders.
Staff
Dr. Michael Erdos is an Associate Investigator in the Molecular Genetics Section of the Center for Precision Health Research.
… translational research to identify and validate potential therapeutics for the rare premature-aging disease, Hutchinson … useful model for preclinical investigation of potential therapeutics, particularly for genetic therapies, because the … human LMNA DNA sequence. In the realm of small molecule therapeutics, farnesyl transferase inhibitors (FTIs) target …